August 12 was International #YouthDay!
@PATHTweets & @NCPI+ collaborated with @mumbaiaids to conduct a 3-day #HIV/STIs treatment & prevention literacy training with youth+ speakers, culminating in an experience sharing session to create +ve impact.
Here are some highlights
With funding from Unitaid and @PSIimpact, @PATHtweets conducted the STAR HIVST project, which aims to understand the feasibility and acceptability of HIVST among KP/high-risk groups and generate evidence to inform HIVST policy in India.
Find out more: https://t.co/f8F8vSvd9W
The journey to the finish line of the @SelfTestAfrica#HIV self-testing study has neither been linear, nor easy. The @PATHtweets team, came together on June 26 to share learnings & pave the way for self-testing in India, for HIV, Hepatitis C & beyond.
@WHO recently reported on our HIVST feasibility & acceptability project in India where 96% of eligible participants found HIV self-testing (HIVST) kits convenient & easy to use. Read more 👉 https://t.co/BWv1ZyyYKd. @UNITAID@NACOINDIA@Ashahegde1@ammakannanm
Our article on delivering hypertension care in private clinics of urban slum areas in Mumbai has been published in the Journal of Human Hypertension
Thank you @DrTomFrieden and @ResolveTSL
for the partnership and support.
https://t.co/FnIgSoqtIB
Our article on delivering hypertension care in private clinics of urban slum areas in Mumbai has been published in the Journal of Human Hypertension
Thank you @DrTomFrieden and @ResolveTSL
for the partnership and support.
https://t.co/FnIgSoqtIB
@PATHtweets, with partners, under STAR III #HIVST, conducted the first phase of the Scientific Paper Writing Workshop to brainstorm ideas and topics for the development of manuscripts for publication in scientific journals. Inaugural address by Shri Alok Saxena, AS&DG #NACO.
Excited to join the @PLOSONE Editorial Board, an #OpenScience journal publishing trusted research in over 200 subject areas across science, engineering, medicine and the related social sciences and humanities.
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study https://t.co/154sEuSYPY